Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
259 studies found for:    nichd AIDS/HIV
Show Display Options
Rank Status Study
21 Unknown  Women-Focused HIV Prevention in the Western Cape
Conditions: HIV;   Substance Abuse;   Violence
Interventions: Behavioral: Woman-Focused Intervention (Women's CoOp);   Behavioral: Nutrition (Attention-Control);   Behavioral: VCT Only
22 Completed Safety and Effectiveness of Emtricitabine, Efavirenz, and Didanosine in HIV Infected Children Who Have Taken Few or No Anti-HIV Drugs
Condition: HIV Infections
Interventions: Drug: Didanosine;   Drug: Efavirenz;   Drug: Emtricitabine
23 Active, not recruiting
Has Results
Safety and Pharmacokinetics (PK) of Raltegravir in HIV (Human Immunodeficiency Virus)-Infected Children and Adolescents
Condition: HIV Infections
Interventions: Drug: Raltegravir poloxamer film coated tablet;   Drug: Raltegravir chewable tablet;   Drug: Raltegravir oral granules for suspension (20 mg/mL)
24 Completed Pre-Exposure Prophylaxis in YMSM
Condition: HIV
Interventions: Drug: coformulated emtricitabine (FTC) and tenofovir disoproxil fumarate (TDF) as PrEP;   Drug: Placebo;   Behavioral: Many Men, Many Voices (3MV)
25 Completed Safety of Tenofovir Disoproxil Fumarate (TDF) and Emtricitabine/TDF in HIV Infected Pregnant Women and Their Infants
Condition: HIV Infections
Interventions: Drug: Emtricitabine/Tenofovir disoproxil fumarate;   Drug: Tenofovir disoproxil fumarate
26 Completed Safety and Effectiveness of Lopinavir/Ritonavir in HIV Infected Infants
Condition: HIV Infections
Intervention: Drug: Lopinavir/Ritonavir
27 Completed
Has Results
Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children
Condition: HIV Infections
Interventions: Drug: NRTIs (ABC, FTC, FTC/TDF, 3TC, 3TC/AZT, d4T, TDF, ddC, AZT);   Drug: NNRTIs (EFV, NVP);   Drug: PIs (AMP, IDV, LPV/r, NFV, SQV, RTV)
28 Completed
Has Results
Safety and Immune Response to Vicriviroc in Combination Regimens in HIV-Infected ART Experienced Children and Adolescents
Condition: HIV Infections
Intervention: Drug: Vicriviroc
29 Active, not recruiting An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis
Condition: HIV Infection
Interventions: Behavioral: 3MV;   Behavioral: PCC;   Drug: Emtricitabine/tenofovir (FTC/TDF (Truvada®))
30 Completed Interleukin-2 Plus Anti-HIV Therapy in HIV-Infected Children With Weakened Immune Systems
Condition: HIV Infections
Interventions: Biological: Diphtheria & Tetanus Toxoids & Acellular Pertussis Vaccine Adsorbed;   Biological: Diphtheria and Tetanus Toxoids Adsorbed;   Biological: Tetanus and Diphtheria Toxoids Adsorbed;   Drug: Bacteriophage phi X 174;   Drug: Aldesleukin
31 Completed Combination Treatment With and Without Protease Inhibitors for Women Who Begin Therapy for HIV Infection During Pregnancy
Conditions: HIV Infections;   Pregnancy
Interventions: Drug: Lamivudine;   Drug: Lamivudine/Zidovudine;   Drug: Nelfinavir mesylate;   Drug: Nevirapine;   Drug: Zidovudine
32 Completed
Has Results
Atazanavir Used in Combination With Other Anti-HIV Drugs in HIV-Infected Infants, Children, and Adolescents
Condition: HIV Infections
Interventions: Drug: ATV;   Drug: Ritonavir
33 Completed Anti-HIV Immunoglobulin (HIVIG) in Prevention of Maternal-Fetal HIV Transmission (Pediatric ACTG Protocol 185)
Conditions: Acquired Immunodeficiency Syndrome;   Disease Transmission, Vertical;   HIV Infections
Intervention: Drug: immunoglobulins
34 Completed A Study of Ritonavir (an Anti-HIV Drug) in HIV-Positive Infants and Children
Condition: HIV Infections
Interventions: Drug: Ritonavir;   Drug: Lamivudine;   Drug: Zidovudine
35 Completed Comparison of Anti-HIV Drug Combinations to Prevent Mother-to-Child Transmission of HIV
Condition: HIV Infections
Interventions: Drug: Abacavir sulfate, lamivudine, and zidovudine;   Drug: Lamivudine/zidovudine;   Drug: Lopinavir/ritonavir
36 Completed
Has Results
Safety of and Immune Response to a Novel Human Papillomavirus Vaccine in HIV Infected Children
Conditions: HIV Infections;   Sexually Transmitted Diseases
Interventions: Biological: Quadrivalent human papillomavirus (types 6, 11, 16, 18) L1 virus-like particle (VLP) or Quadrivalent human papillomavirus vaccine (QHPV);   Other: Placebo/QHPV
37 Completed The Effects of Anti-HIV Therapy on the Immune Systems of Children and Young Adults Infected With HIV
Condition: HIV Infections
Interventions: Biological: Tetanus toxoid;   Biological: Hepatitis A Vaccine (Inactivated)
38 Enrolling by invitation Community Intervention for HIV Testing & Care Linkage Among Young MSM in Bulgaria
Conditions: Acquired Immunodeficiency Syndrome;   HIV
Interventions: Behavioral: Social Network Leader Endorsement;   Behavioral: HIV Counseling
39 Completed Anti-HIV Drug Regimens With or Without Protease Inhibitors and Drug Level Monitoring in HIV Infected Adolescents
Condition: HIV Infections
Interventions: Drug: Efavirenz + 2 NRTIs;   Drug: Lopinavir/Ritonavir + 2 NRTIs;   Procedure: Therapeutic Drug Monitoring
40 Completed A Study to Test the Safety, Tolerance, and Metabolism of Abacavir (1592U89, ABC) With Standard Zidovudine (ZDV) Therapy in Newborn Infants Born to HIV-1 Infected Women
Condition: HIV Infections
Interventions: Drug: Abacavir sulfate;   Drug: Zidovudine

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.